ENDRA Life Sciences Inc. (NDRA) financial statements (2022 and earlier)

Company profile

Business Address 3600 GREEN COURT
ANN ARBOR, MI 48105
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,46211,79314,04316,8437,2273,793749
Cash and cash equivalents9,46211,79314,04316,8437,2273,793749
Inventory, net of allowances, customer advances and progress billings1,2851,5001,325727590323341
Inventory1,2851,5001,325727590323341
Prepaid expense 1,1779697763915621,064
Other current assets  666101122
Total current assets:10,74614,47016,34318,3518,2144,7802,275
Noncurrent Assets
Operating lease, right-of-use asset643676708322339356373
Property, plant and equipment131162192226212226215
Other noncurrent assets 6     
Total noncurrent assets:775844900547551582587
TOTAL ASSETS:11,52115,31417,24318,8998,7655,3612,863
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,4111,149 5829101,028969
Accounts payable791748 448403874495
Accrued liabilities 205    315
Employee-related liabilities101196 13448154159
Other undisclosed accounts payable and accrued liabilities519   459  
Other undisclosed current liabilities 4281,63818476371271
Total current liabilities:1,4111,5771,6387669871,3991,240
Noncurrent Liabilities
Long-term debt and lease obligation518581615281609628645
Long-term debt, excluding current maturities 58161528337337337
Operating lease, liability518  252272290308
Other undisclosed noncurrent liabilities   (252) (290)(308)
Total noncurrent liabilities:518581615281609628645
Total liabilities:2,4482,1582,2531,0471,5962,0261,886
Stockholders' equity
Stockholders' equity attributable to parent, including:10,78413,15614,99017,8527,1693,335977
Common stock 444332
Additional paid in capital 78,69577,83977,46164,49458,28252,228
Accumulated deficit(68,691)(65,586)(62,928)(59,729)(57,338)(55,088)(51,434)
Other undisclosed stockholders' equity attributable to parent79,475437511611139181
Total stockholders' equity:10,78413,15614,99017,8527,1693,335977
TOTAL LIABILITIES AND EQUITY:13,23215,31417,24318,8998,7655,3612,863

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Operating expenses(3,072)(2,651)(3,200)(2,576)(2,254)(3,255)(2,891)
Operating loss:(3,072)(2,651)(3,200)(2,576)(2,254)(3,255)(2,891)
Nonoperating income (expense)(33)(8)13074(3)(3)
Other nonoperating income (expense)(33)(8)1(2)4(3)1
Interest and debt expense   309   
Other undisclosed loss from continuing operations before equity method investments, income taxes(309)      
Loss from continuing operations before equity method investments, income taxes:(3,413)(2,658)(3,199)(1,961)(2,251)(3,258)(2,894)
Other undisclosed income (loss) from continuing operations before income taxes309  (309)   
Loss before gain (loss) on sale of properties:(3,105)(2,658)(3,199)(2,269)(2,251)(3,258)(2,894)
Other undisclosed net income22,463      
Net income (loss):19,358(2,658)(3,199)(2,269)(2,251)(3,258)(2,894)
Other undisclosed net loss attributable to parent(22,463)      
Net loss attributable to parent:(3,105)(2,658)(3,199)(2,269)(2,251)(3,258)(2,894)
Other undisclosed net loss available to common stockholders, basic   (121) (396) 
Net loss available to common stockholders, diluted:(3,105)(2,658)(3,199)(2,390)(2,251)(3,654)(2,894)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):19,358(2,658)(3,199)(2,269)(2,251)(3,258)(2,894)
Comprehensive income (loss), net of tax, attributable to parent:19,358(2,658)(3,199)(2,269)(2,251)(3,258)(2,894)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: